Objective: To assess the reliability of thyroglobulin (Tg) as a marker of iodine status during pregnancy. Design: 299 women aged 30.5 ± 4.8 years (mean ± SD) were studied. Methods: In every subject, we measured urinary iodine concentration (UIC), serum thyrotropin (TSH), Tg, free thyroxine (fT4), Tg autoantibodies (TgAbs) and human chorionic gonadotropin (hCG) levels. We excluded samples with increased TgAbs from the analysis. Results: According to WHO criteria, the study population was iodine deficient in every trimester. Serum Tg levels did not differ during the three trimesters of pregnancy. Serum hCG levels fell significantly as pregnancies advanced. A weak, significantly negative correlation (limited to the 3rd trimester) was found between Tg and UIC (ρ = -0.187, p = 0.039). Serum fT4 decreased as pregnancies advanced and TSH increased. Serum fT4 was negatively correlated with TSH (ρ = -0.161, p = 0.006) and positively with hCG (ρ = +0.165, p = 0.005). The multiple regression equation of Tg based on hCG, TSH, UIC and trimester of pregnancy was significant but weak (F = 4.057, p = 0.003; R2 = 0.055), with hCG as a significant predictor Tg (p for log hCG = 0.041). Conclusions: Tg cannot be considered as a valid marker of iodine deficiency in pregnancy, at least in a mildly iodine-deficient environment. Further studies in a larger patient cohort with differences in iodine status, as well as studies on Tg changes after improving iodine status in pregnant women, are needed in order to corroborate these results.

Keywords:
Thyroglobulin, Pregnancy, Human chorionic gonadotropin, Iodine, Iodine deficiency
1.
Gahche JJ, Bailey RL, Mirel LB, Dwyer JT: The prevalence of using iodine-containing supplements is low among reproductive-age women, NHANES 1999-2006. J Nutr 2013;143:872-877.
2.
Brantsaeter AL, Abel MH, Haugen M, Meltzer HM: Risk of suboptimal iodine intake in pregnant Norwegian women. Nutrients 2013;5:424-440.
3.
Younes-Rapozo V, Berendonk J, Savignon T, Manhaes AC, Barradas PC: Thyroid hormone deficiency changes the distribution of oligodendrocyte/myelin markers during oligodendroglial differentiation in vitro. Int J Dev Neurosci 2006;24:445-453.
4.
De Escobar GM, Obregon MJ, Del Rey FE: Iodine deficiency and brain development in the first half of pregnancy. Public Health Nutr 2007;10:1554-1570.
5.
Zimmermann MB: Iodine deficiency. Endocr Rev 2009;30:376-408.
6.
Bath SC, Steer CD, Golding J, Emmett P, Rayman MP: Effect of inadequate iodine status in UK pregnant women on cognitive outcomes in their children: results from the Avon Longitudinal Study of Parents and Children (ALSPAC). Lancet 2013;382:331-337.
7.
Hynes KL, Otahal P, Hay I, Burgess JR: Mild iodine deficiency during pregnancy is associated with reduced educational outcomes in the offspring: 9-year follow-up of the gestational iodine cohort. J Clin Endocrinol Metab 2013;98:1954-1962.
8.
World Health Organization; United Nations Children's Fund; International Council for the Control of Iodine Deficiency Disorders: Assessment of Iodine Deficiency Disorders and Monitoring Their Elimination, ed 3. Geneva, WHO, 2007.
9.
Andersen S, Karmisholt J, Pedersen KM, Laurberg P: Reliability of studies of iodine intake and recommendations for number of samples in groups and in individuals. Br J Nutr 2008;99:813-818.
10.
van den Briel T, West CE, Hautvast JG, Vulsma T, de Vijlder JJ, Ategbo EA: Serum thyroglobulin and urinary iodine concentration are the most appropriate indicators of iodine status and thyroid function under conditions of increasing iodine supply in schoolchildren in Benin. J Nutr 2001;131:2701-2706.
11.
Zimmermann MB: Assessing iodine status and monitoring progress of iodized salt programs. J Nutr 2004;134:1673-1677.
12.
Fantz CR, Dagogo-Jack S, Ladenson JH, Gronowski AM: Thyroid function during pregnancy. Clin Chem 1999;45:2250-2258.
13.
Koukkou E, Kravaritis S, Mamali I, Markantes GG, Michalaki M, Adonakis GG, Georgopoulos NA, Markou KB: No increase in renal iodine excretion during pregnancy: a telling comparison between pregnant women and their spouses. Hormones (Athens) 2014;13:375-381.
14.
Dunn JT, Crutchfield HE, Gutekunst R, Dunn AD: Two simple methods for measuring iodine in urine. Thyroid 1993;3:119-123.
15.
Pearce EN, Alexiou M, Koukkou E, Braverman LE, He X, Ilias I, Alevizaki M, Markou KB: Perchlorate and thiocyanate exposure and thyroid function in first-trimester pregnant women from Greece. Clin Endocrinol (Oxf) 2012;77:471-474.
16.
Zimmermann MB, Gizak M, Abbott K, Andersson M, Lazarus JH: Iodine deficiency in pregnant women in Europe. Lancet Diabetes Endocrinol 2015;3:672-674.
17.
Vejbjerg P, Knudsen N, Perrild H, Laurberg P, Carlé A, Pedersen IB, Rasmussen LB, Ovesen L, Jørgensen T: Thyroglobulin as a marker of iodine nutrition status in the general population. Eur J Endocrinol 2009;161:475-481.
18.
Zimmermann MB, Aeberli I, Andersson M, Assey V, Yorg JA, Jooste P, Jukić T, Kartono D, Kusić Z, Pretell E, San Luis TO Jr, Untoro J, Timmer A: Thyroglobulin is a sensitive measure of both deficient and excess iodine intakes in children and indicates no adverse effects on thyroid function in the UIC range of 100-299 μg/l: a UNICEF/ICCIDD study group report. J Clin Endocrinol Metab 2013;98:1271-1280.
19.
Pedersen KM, Borlum KG, Knudsen PR, Hansen ES, Johannesen PL, Laurberg P: Urinary iodine excretion is low and serum thyroglobulin high in pregnant women in parts of Denmark. Acta Obstet Gyncol Scand 1988;67:413-416.
20.
Ma ZF, Skeaff SA: Thyroglobulin as a biomarker of iodine deficiency: a review. Thyroid 2014;24:1195-1209.
21.
Eltom A, Elnagar B, Elbagir M, Gebre-Medhin M: Thyroglobulin in serum as an indicator of iodine status during pregnancy. Scand J Clin Lab Invest 2000;60:1-7.
22.
Brucker-Davis F, Ferrari P, Gal J, Berthier F, Fenichel P, Hieronimus S: Iodine status has no impact on thyroid function in early healthy pregnancy. J Thyroid Res 2012;2012:168764.
23.
Raverot V, Bournaud C, Sassolas G, Orgiazzi J, Claustrat F, Gaucherand P, Mellier G, Claustrat B, Borson-Chazot F, Zimmermann M: Pregnant French women living in the Lyon area are iodine deficient and have elevated serum thyroglobulin concentrations. Thyroid 2012;22:522-528.
24.
Andersen SL, Nøhr SB, Wu CS, Olsen J, Pedersen KM, Laurberg P: Thyroglobulin in smoking mothers and their newborns at delivery suggests autoregulation of placental iodide transport overcoming thiocyanate inhibition. Eur J Endocrinol 2013;168:723-731.
25.
Brough L, Jin Y, Shukri NH, Wharemate ZR, Weber JL, Coad J: Iodine intake and status during pregnancy and lactation before and after government initiatives to improve iodine status, in Palmerston North, New Zealand: a pilot study. Matern Child Nutr 2015;11:646-655.
26.
Costeira MJ, Oliveira P, Ares S, Roque S, de Escobar GM, Palha JA: Parameters of thyroid function throughout and after pregnancy in an iodine-deficient population. Thyroid 2010;20:995-1001.
27.
Swanson CA, Pearce EN: Iodine insufficiency: a global health problem? Adv Nutr 2013;4:533-535.
28.
Rebagliato M, Murcia M, Alvarez-Pedrerol M, Espada M, Fernández-Somoano A, Lertxundi N, Navarrete-Muñoz EM, Forns J, Aranbarri A, Llop S, Julvez J, Tardón A, Ballester F: Iodine supplementation during pregnancy and infant neuropsychological development. INMA Mother and Child Cohort Study. Am J Epidemiol 2013;177:944-953.
29.
Taylor PN, Okosieme OE, Dayan CM, Lazarus JH: Therapy of endocrine disease: impact of iodine supplementation in mild-to-moderate iodine deficiency: systematic review and meta-analysis. Eur J Endocrinol 2014;170:R1-R15.
30.
Gunnarsdottir I, Dahl L: Iodine intake in human nutrition: a systematic literature review. Food Nutr Res 2012;56:10.3402/fnr.v3456i3400.19731.
31.
König F, Andersson M, Hotz K, Aeberli I, Zimmermann MB: Ten repeat collections for urinary iodine from spot samples or 24-hour samples are needed to reliably estimate individual iodine status in women. J Nutr 2011;141:2049-2054.
32.
de Vijlder JJ, Ris-Stalpers C, Vulsma T: On the origin of circulating thyroglobulin. Eur J Endocrinol 1999;140:7-8.
33.
Spencer CA, Wang CC: Thyroglobulin measurement. Techniques, clinical benefits, and pitfalls. Endocrinol Metab Clin North Am 1995;24:841-863.
34.
Baloch Z, Carayon P, Conte-Devolx B, Demers LM, Feldt-Rasmussen U, Henry JF, LiVosli VA, Niccoli-Sire P, John R, Ruf J, Smyth PP, Spencer CA, Stockigt JR: Laboratory medicine practice guidelines. Laboratory support for the diagnosis and monitoring of thyroid disease. Thyroid 2003;13:3-126.
35.
Hershman JM: Physiological and pathological aspects of the effect of human chorionic gonadotropin on the thyroid. Best Pract Res Clin Endocrinol Metab 2004;18:249-265.
36.
Albertson BD, Vaitukaitis JL: Role of cyclic nucleotides in modulating ovarian hCG action. Endocr Res Commun 1977;4:367-378.
37.
Zimmermann MB: The role of iodine in human growth and development. Semin Cell Dev Biol 2011;22:645-652.
38.
Glinoer D: Pregnancy and iodine. Thyroid 2001;11:471-481.
© 2016 European Thyroid Association Published by S. Karger AG, Basel
2016
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.